ASYMCHEM
In line with Asymchem’s continuous strategic layout and development, the organization has welcomed Dr. Cheng Yi Chen as a senior executive.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240626665787/en/
Asymchem is pleased to announce Dr. Cheng Yi Chen has joined Asymchem as Small-Molecule Sector CTO. (Photo: Business Wire)
Dr. Cheng Yi Chen officially joined Asymchem as CTO of the Small-Molecule Sector on June 18, 2024. He will report directly to Asymchem’s CEO, Dr. Hao Hong. In this position, Dr. Cheng Yi Chen will provide technical support to the group’s chemical small molecule sales in the European and United States markets. His main duties include active participation in technical communications for key mid-to-late-stage clinical projects in Europe and United States and facilitating collaborations with crucial new clients by capitalizing on the overall technical capabilities of the group’s chemical small-molecule sector. He will also offer guidance to the China Core Team on project-related technical matters with European and United States clientele and provide advisory input for communication. Additionally, he will provide technical expertise suggestions for the Boston site in the United States, as well as supervising technical operations at small-molecule laboratories and pilot production sites across Europe.
Dr. Chen worked at Merck Research Laboratories, Janssen Pharmaceuticals of Johnson & Johnson, Mirati Therapeutics, and Bristol Myers Squibb before joining Asymchem. He has extensive experience designing, developing, and implementing robust, cost-effective, and green manufacturing routes for small molecule APIs, ensuring CMC compliance and quality, collaborating with cross-functional drug development teams and external partners, and supporting regulatory filings. Dr. Chen received his Ph.D. in organic chemistry from The Ohio State University.
About Asymchem
Asymchem is a comprehensive contract development and manufacturing organization (CDMO) with a complete continuum of support from preclinical to commercialization. Founded in 1997, Asymchem offers integrated solutions spanning the entire drug substance and drug product life cycle, backed by cutting-edge technology including flow chemistry and green manufacturing. With R&D and manufacturing operations in China, Europe, and the U.S. and a team of proven experts, we provide a full range of CDMO services for a global client base.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240626665787/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Venture Global, Inc. Announces Pricing of its Initial Public Offering24.1.2025 01:04:00 CET | Press release
Venture Global, Inc. (“Venture Global”) announced today the pricing of its initial public offering of 70,000,000 shares of its Class A common stock, par value $0.01 (“Class A common stock”) at a public offering price of $25.00 per share. In connection with the offering, Venture Global has granted the underwriters a 30-day option to purchase up to an additional 10,500,000 shares of Class A common stock. The shares of Class A common stock are expected to begin trading on the New York Stock Exchange on January 24, 2025 under the symbol “VG”. The closing of the offering is expected to occur on January 27, 2025, subject to the satisfaction of customary closing conditions. Goldman Sachs & Co. LLC, J.P. Morgan (each listed alphabetically) and BofA Securities are acting as joint lead book-running managers. ING, RBC Capital Markets, Scotiabank, Mizuho, Santander, SMBC Nikko, MUFG, BBVA, Loop Capital Markets, Natixis, Deutsche Bank Securities, Wells Fargo Securities and Truist Securities are act
IFF to Release Fourth Quarter & Full Year 2024 Results on Feb. 18, 2025; IFF to Present at 2025 CAGNY Conference on Feb. 20, 202523.1.2025 22:24:00 CET | Press release
IFF (NYSE:IFF) today announced that it will release its fourth quarter and full year 2024 earnings results following the market close on Tuesday, Feb. 18, 2025. The management team will host a live webcast on Wednesday, Feb. 19, 2025, at 9:00 a.m. ET to discuss results and outlook with the investor community. IFF also announced today that the Company’s management will speak at the Consumer Analyst Group of New York (CAGNY) conference on Thursday, Feb. 20, 2025 at 1:00 PM ET. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enh
AIT Worldwide Logistics executives appointed to new leadership roles23.1.2025 20:04:00 CET | Press release
Chief Development Officer, Ray Fennelly, Chief Information Officer, Ann Nemphos, to guide company towards achieving five-year goals AIT Worldwide Logistics, a global supply chain solutions leader, has named Ray Fennelly to the position of chief development officer (CDO) and Ann Nemphos to chief information officer (CIO). This executive management reorganization improves the alignment of the company’s top leadership with its five-year growth strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250123094755/en/ In their newly-appointed roles, Chief Development Officer, Ray Fennelly, and Chief Information Officer, Ann Nemphos, are positioned to boost support for AIT’s five-year strategic plan. (Photo: Business Wire) Fennelly, a veteran of both the company and the logistics industry, started with AIT 30 years ago and has held numerous leadership roles in that time, most recently serving as CIO. He has been intimately involve
SES Announces Completion of €100m Open Market Repurchase of its NC625 Securities23.1.2025 18:58:00 CET | Press release
SES S.A. announces it has repurchased in the open market an aggregate amount of €99,978,000 principal amount of its €625,000,000 Deeply Subordinated Fixed Rate Resettable Securities issued on 27 May 2021. In accordance with the terms and conditions of the Securities, the purchased Securities will be cancelled. Following these transactions, the outstanding principal amount of the Securities is €525,022,000. Payment in relation to the Securities will be made in accordance with the usual procedures of Clearstream, Luxembourg and/or Euroclear. The success of these transactions reduces SES's outstanding debt obligation, demonstrating SES’s financial flexibility and its strong cash-generation profile. SES may seek to make further repurchases of its Securities from time to time, subject to market conditions. This announcement does not constitute or form part of an offer to sell or purchase, or a solicitation of an offer to sell or purchase the Securities or any other securities. Follow us on:
InMotion Ventures Invests $2 Million in Cyclic Materials, Extending Series B to $55 Million23.1.2025 15:00:00 CET | Press release
The Series B funding will be used to support the opening of Cyclic Materials’ first commercial facilities in the US and Europe Cyclic Materials, the advanced recycling company building a circular supply chain for Rare Earth Elements and other critical materials, today announced a $2 million investment from InMotion Ventures, the investment arm of Jaguar Land Rover (JLR). This latest backing lifts the company’s Series B round to $55 million, underscoring its critical role in advancing sustainable supply chains for the automotive industry and beyond. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250123234060/en/ Cyclic Materials extracts REEs from various end-of-life products, including EVs, consumer electronics, and medical equipment. Pictured are recycled EV and hybrid vehicle motors. (Photo: Business Wire) Rare Earth Elements (REEs) are an essential component in permanent magnets, which are found in everything from data ce
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom